Rbwin Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Minii Life Sciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Rbwin Trio 1mg/500mg/0.2mg Tablet SR
Tridyn 1mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer Tridyn with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Rbwin Trio 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Rbwin Trio 1mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Rbwin Trio 1mg/500mg/0.2mg Tablet SR should be swallowed whole; do not break, chew, or crush it. Administer this tablet on an empty stomach.
Common Side effects of Rbwin Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Rbwin Trio 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Rbwin Trio 1mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
How Rbwin Trio 1mg/500mg/0.2mg Tablet SR works:
The extended-release Rbwin Trio tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Rbwin Trio 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rbwin Trio 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rbwin Trio 1mg/500mg/0.2mg tablet is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Rbwin Trio 1mg/500mg/0.2mg SR tablets are likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Rbwin Trio 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. Mild to moderate hepatic dysfunction may necessitate initiating Rbwin Trio 1mg/500mg/0.2mg Tablet SR at a reduced dosage; however, its use is contraindicated in severe liver disease.
What if you forget to take Rbwin Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget a dose of Rbwin Trio 1mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rbwin Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently